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Abstract
Objectives Our goal is to determine the ability of multi-
parametric magnetic resonance imaging (mpMRI) to differen-
tiate muscle invasive bladder cancer (MIBC) from non-
muscle invasive bladder cancer (NMIBC).
Methods Patients underwent mpMRI before tumour resec-
tion. Four MRI sets, i.e. T2-weighted (T2W) + perfusion-
weighted imaging (PWI), T2W plus diffusion-weighted imag-
ing (DWI), T2W+DWI + PWI, and T2W+DWI + PWI + dif-
fusion tensor imaging (DTI) were interpreted qualitatively by
two radiologists, blinded to histology results. PWI, DWI and
DTI were also analysed quantitatively. Accuracy was deter-
mined using histopathology as the reference standard.
Results A total of 82 tumours were analysed. Ninety-six per-
cent of T1-labeled tumours by the T2W+DWI + PWI image
set were confirmed to be NMIBC at histopathology. Overall
accuracy of the complete mpMRI protocol was 94% in differ-
entiating NMIBC from MIBC. PWI, DWI and DTI quantita-
tive parameters were shown to be significantly different in
cancerous versus non-cancerous areas within the bladder wall
in T2-labelled lesions.
Conclusions MpMRI with DWI and DTI appears a reliable
staging tool for bladder cancer. If our data are validated, then
mpMRI could precede cystoscopic resection to allow a faster
recognition of MIBC and accelerated treatment pathways.
Key Points
• A critical step in BCa staging is to differentiate NMIBC
from MIBC.
• Morphological and functional sequences are reliable
techniques in differentiating NMIBC from MIBC.
• Diffusion tensor imaging could be an additional tool in
BCa staging.
Keywords Bladder cancer . Multiparametric magnetic
resonance imaging . Diffusion-weighted imaging . Diffusion
tensor imaging . Staging
Introduction
Bladder cancer (BCa) is a common cancer worldwide and one
of the most expensive to manage [1, 2]. This disease accounts
for 6–8% of all male malignancies and 2–3% in women,
reflecting aetiological factors [3, 4]. The tumour is best clas-
sified as either non-muscle invasive (NMIBC) or muscle-
invasive (MIBC) as this reflects the biology and alters the
treatment intent [5]. Most deaths occur from MIBC, which
must be treated radically if cure is to be obtained.Whilst many
NMIBC are indolent tumours, around one- third are high
grade and can rapidly progress to muscle invasion and metas-
tases [6, 7]. As such, the prognosis and treatment of patients
with BCa requires accurate staging at the time of diagnosis.
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Staging of BCa depends upon clinical, radiological and
pathological features. The former are obtained from endo-
scopic appearances and patient features, whilst the latter re-
flect the material obtained by transurethral resection (TUR).
Conflicting results between these staging tools are common.
Whilst TUR is the cornerstone of BCa staging, it is recognized
to both under- and overstage cancers. Up to one- third of
invasive BCa are initially staged as NMIBC at TUR [8], and
residual tumour rates following TUR vary considerably,
reflecting user dependency of this procedure [9].
Given the limitations of current clinical staging approaches,
improved radiological tools are needed. Magnetic resonance
imaging (MRI) is an accurate technique that provides a high
tissue contrast resolution, being able to differentiate the layers
of the bladder wall without administration of radiation.
Although a number of studies have shown little difference
in the accuracy of multiple detector computed tomography
(MDCT) and MRI for BCa staging [10], recent improvements
in MRI technology and new functional MR sequences such as
diffusion- weighted imaging (DWI) and perfusion-weighted
imaging (PWI) suggest it is time to review the accuracy of
contemporary MRI. The aim of this current study is to exam-
ine the accuracy of morphological and functional mpMRI
sequences in differentiating NMIBC from MIBC. Tested se-
quences include PWI, DWI and diffusion tensor imaging
(DTI), with the fractional anisotropy (FA) methodology and
fibre tractography (FT).
Materials and methods
Patient population
Between January and November 2016, 76 consecutive pa-
tients with suspected or confirmed bladder lesions were en-
rolled in the study, following institutional review board ap-
proval. All patients underwentMRI and then bladder resection
within the following 2–8 weeks. We selected patients with
normal renal function whose cytology, ultrasound (US) and/
or cystoscopy suggested bladder cancer, and obtained written
informed consent. We excluded patients with renal impair-
ment, those who did not provide consent and those who could
not attain adequate bladder distension. Prior to MRI evalua-
tion by the readers, MRI examinations of patients with locally
advanced BCa (pT3-4) and whose bladder resection did not
reveal BCa were excluded.
MR image acquisition
Prior to the MRI, patients received bowel preparation for 24 h
and intramuscular administration of Buscopan® 1 ml
(20 mg/ml) just before imaging. Patients voided urine 1 h
before the MRI and then drank water until the scan. Studies
were performed at a 3 TMRI scanner (DiscoveryMR750, GE
Healthcare, Milwaukee, WI, USA) equipped with a 32-
channel pelvic phased-array coil (HD Body, GE Healthcare).
Patients were positioned with the bladder at the coil isocentre.
The entire pelvis was imaged from the aortic bifurcation to the
inferior margin of the pubic symphysis.
MR sequences
Turbo spin-echo T2-weighted (T2W) images (TR/TE, 8,000/
120 ms; matrix, 320x320; section thickness, 3 mm; field of
view, 23 cm;) were obtained in axial and sagittal planes. DW
images were obtained during free-breathing in the axial plane
by using a single-shot spin-echo echoplanar sequence with
chemical shift-selective fat-suppression techniques (b, 0-
500-800-1,000 s/mm2; TR/TE, 5,300/60 ms; matrix,
128x96; section thickness, 3 mm; field of view, 24 cm).
PWI images were acquired with a temporal resolution of 5 s
(TR/TE, 2.9/1.3 ms; flip angle, 15°; matrix, 192x138; section
thickness, 3 mm), 20–180 s after intravenous administration
of 0.1 mmol/kg of gadobutrol (Gadovist, Bayer Schering
Pharma, Berlin, Germany) at a rate of 3 ml/s. T1-weighted
images were obtained post contrast medium injection with a
fat-suppressed 3D volumetric spoiled gradient-echo sequence
(TR/TE, 16.4/4.7 ms; flip angle, 15°; section thickness, 3 mm;
matrix, 352x352) aimed at complete pelvic examination. DTI
data were acquired using a sequence with the following pa-
rameters: b-value of 0-1,000 s/mm2; 16 different gradient di-
rections, TR/TE, 2,000/80 ms; slice thickness, 3 mm; matrix
size, 96x96; field of view, 24 cm.
MRI data analysis
Images were independently analysed in two reading sessions
(2 weeks apart) by two radiologists with 10 and 3 years of
urogenital experience, respectively. Disagreements were re-
solved by consensus. Four image sets (T2W plus PWI, T2W
plus DWI, T2W plus DWI plus PWI and T2W plus DWI plus
PWI plus DTI) for each patient were interpreted qualitatively
without knowledge of the surgical or histological findings.
During the first session, each radiologist interpreted T2W
plus PWI images according to criteria previously described in
the literature [11, 12] without formulating a definitive diagno-
sis of muscular invasion. On T2W images the bladder wall
was considered to be intact (stage T1 or lower) when the low
SI line which represents the normal bladder wall was present.
On contrast-enhanced images, an intact submucosal linear en-
hancement adjacent to a tumour and no enhancement of the
muscle layer, which is indicative of a normal wall, was
regarded as indicative of stage T1 or lower. In the second
session, the remaining images were analysed, including
DWI sequences and DTI imaging results, which were
assessed both qualitatively and quantitatively. DWI and the
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corresponding apparent diffusion coefficient (ADC) maps
were interpreted using staging criteria described in the litera-
ture. At DWI, a focal high signal intensity (SI) area corre-
sponds to the tumour. A high SI tumour with a low SI submu-
cosa [13] was considered as stage T1 or lower; a high SI
tumour without a low SI submucosal lining was classified as
T2 or higher.When a stalk is present, in a T1 lesion it is shown
as a low SI structure. DTI data were assessed qualitatively
using FT images, where non-invasive cancer shows even col-
ours and regular arrangement of muscle fibres; invasive can-
cer shows irregular arrangement and directions of muscle fi-
bres. DTI was used where there was inconsistency between
PWI and DWI: if detrusor muscle invasion was suspected on
FT images, a lesion was categorized as T2, otherwise it was
labelled as T1. Detrusor muscle invasion was scored accord-
ing to criteria described in the literature as follows: 1, probably
absent; 2, possibly absent; 3, slightly suspicious; 4, possibly
present; or 5, probably present.
Quantitative analysis was based on the results of the third
image set (T2W+ PWI +DWI), which was used to formulate
the definitive report. All cases considered at least as Bslightly
suspicious^ (i.e. all cases with a score ≥ 3) after reading the
aforementioned image set (34 lesions) were analysed separate-
ly from the others (48 lesions). Three regions of interest
(ROIs) were considered, placed respectively: on the
intravesical tumour (ROI 1), at the bladder wall immediately
below the lesion (ROI 2: detrusor/tumour interface) between
the bladder mucosa and detrusor muscle, and on a normal
detrusor muscle remote from the lesion (ROI 3).
As regards quantitative evaluation of PWI, we considered
the k-trans value as a robust parameter since it allows evalu-
ation of capillary permeability, which is indicative of the un-
derlying tissue physiology, particularly the rate of tumour
neoangiogenesis [14, 15]. It is also relatively independent
from the method of measurement. On PWI images the soft-
ware calculated the k-trans for each ROI automatically.
On ADC maps, each ROI was measured three times, and
an average ADC was used for statistical analysis.
DTI images data were obtained as follows: T2-DWI fusion
images were used in order to put the ROIs on the same level as
the ADC maps. For each ROI, ADC and FAwere calculated
and expressed as medians with interquartile ranges (IQRs).
Statistical analysis
Sensitivity, specificity, positive predictive value (PPV), nega-
tive predictive value (NPV) and accuracy in detecting muscle
invasion were calculated for all image sets, and receiver oper-
ating characteristic (ROC) curves were generated. Muscular
invasion was defined using histological material resected from
the bladder. Comparisons between PWI, ADC and DTI quan-
titative parameters (k-trans, ADC value and FA) for the three
different ROIs were performed by the Friedman test. Post-hoc
tests were performed by the Wilcoxon signed-rank test with
Bonferroni correction for the following comparisons: intra-
cavity tumour versus detrusor muscle invasion (ROI1 vs.
ROI2) and detrusor muscle invasion versus normal remote
detrusor muscle (ROI2 vs. ROI3). ROC curves were used to
examine the diagnostic performance of DTI parameters versus
ADC values to distinguish cancerous areas versus non-
cancerous areas within the detrusor muscle (ROI2 vs.
ROI3). All statistical analyses were two-sided and performed
within MedCalc software for Windows v.14.8.1 (MedCalc
Software, Ostend, Belgium). Statistical significance was de-
fined as p < 0.05.
Results
Patients and tumours
In total, 76 patients entered the study, including 46 undergoing
TUR, four undergoing partial cystectomy and 26 undergoing
radical cystectomy. Two patients were excluded for lack of
BCa on histology and four because tumour stage could not
be accurately defined histologically. The remaining patients
included 56 men and 14 women, with an age range of 45–
80 years (mean ± SD: 66 ± 1). A total of 92 lesions were
resected, 54 from solitary tumours and 38 from multifocal
BCa. Solitary tumours were staged as pTa-1 (n = 23), pT2
(n = 25) pT3 (n = 5) and pT4 (n = 1). Sixteen patients had
multifocal BCa, staged as follows: pTa-1 (n = 30; six patients
had two foci and six patients had three foci); pT2 (n = 4, two
patients with two lesions each); pT4 (n = 4, two patients had
two tumours). We excluded ten pT3-4 tumours, leaving a final
total of 82 lesions for analysis.
MRI findings: overview
MR images were scored from 1 to 5 according to radiological
likelihood of muscle invasion and compared to histological
findings (Fig. 1a, b and Table 1). Agreement between the
two radiologists for muscle invasion was excellent (kappa
values of 0.904 for T2W plus PWI, 0.924 for T2W plus
DWI, 0.908 for T2W plus PWI plus DWI and 0.953 for
T2W plus PWI plus DWI plus DTI).
For the third image set (T2W+ PWI + DWI), there were
only five discrepancies between the two readers: to formulate
the definitive report, disagreements were resolved assuming
the most experienced radiologist’s interpretation as the correct
one, except for obvious oversights.
The greatest accuracy for invasion was seen with all MR
sequences (T2W, PWI, DWI and DTI: AUROC 0.99), com-
pared to only T2W with PWI (AUROC 0.72) (Fig. 2a).
Both readers overstaged 25/53 NMIBC on the T2W with
PWI image set. DTI helped to correctly categorize four
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Fig. 1 Multiparametric magnetic resonance imaging (mpMRI) of the
bladder. (a) Invasive bladder cancer depicted respectively on A
morphological T2W image as a loss of wall continuity and on
diffusion-weighted image as a focal interruption of the low SI of the
muscular wall. A related apparent diffusion coefficient (ADC) map for
quantitative evaluation is shown. Diffusion tensor imaging (DTI)
reconstruction demonstrates uneven fibre arrangement in the bladder
wall; note in the same zone a strong and focal enhancement involving
detrusor muscle layer on perfusion imaging. (b) Non-invasive bladder
cancer depicted respectively on a morphological T2W image as a
conserved wall continuity and on diffusion-weighted imaging (DWI) as
homogeneous cell density of muscle layer, consistent with integrity of
detrusor muscle. A related ADC map for quantitative evaluation is
shown. DTI reconstruction shows even fibres in the wall. Focal and
strong enhancement of the lesion with homogeneous and diffuse wall
enhancement is shown on perfusion imaging. In both Figs. 1a and 1b,
quantitative data concerning DWI (ADC), PWI (KTrans) and DTI (FA)
are reported, calculated from three regions of interest (ROIs) placed
respectively on: the intravesical tumour (ROI 1), at the tumour/bladder
wall interface (ROI 2) and on normal detrusor muscle remote from the
lesion (ROI 3)
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suspicious pT2 lesions as NMIBC and gave more confidence
in categorizing four pT2 tumours in which muscle invasion
was regarded as ‘slightly suspicious’ (Table 1).
MRI findings: vascular permeability in the tumour
and detrusor muscle
Quantitative analysis in three different ROIs for vascular
permeability (k-trans) in the PWI images (after reading
T2W + PWI + DWI images) are shown in Fig. 3. The
greatest permeability was present within the intra-luminal
tumour (ROI 1) and in the detrusor wall (ROI 2) for muscle
invasive cancers (Friedman test p < 0.001). No significant
difference in k-trans values was seen for the detrusor/
tumour interface or distant detrusor for pTa-1 tumours.
ADC values across three different ROIs are shown in
Fig. 4. Statistical analysis revealed that the distribution of
ADCs differed significantly among the three ROIs
Table 1 Magnetic resonance
imaging interpretation of muscle
invasion when compared to a
reference histological (pTa-1 vs.
pT2) standard
Results pTa-1 pT2 AUROC
n % n %
T2W+ PWI 1. Probably absent 4 100 0 0
2. Possibly absent 24 86 4 14
3. Slightly suspicious 5 45 6 55
4. Possibly present 7 70 3 30
5. Probably present 13 45 16 55 0.716 (0.606–0.810)
T2W+DWI 1. Probably absent 39 100 0 0
2. Possibly absent 9 69 4 31
3. Slightly suspicious 5 45 6 55
4. Possibly present 0 0 0 0
5. Probably present 0 0 19 100 0.966 (0.900–0.993)
T2W+ PWI
+ DWI
1. Probably absent 40 100 0 0
2. Possibly absent 6 75 2 25
3. Slightly suspicious 4 50 4 50
4. Possibly present 3 60 2 30
5. Probably present 0 0 21 100 0.972 (0.909–0.996)
T2W+ PWI
+ DWI +DTI
1. Probably absent 43 100 0 0
2. Possibly absent 7 78 2 22
3. Slightly suspicious 3 100 0 0
4. Possibly present 0 0 3 100
5. Probably present 0 0 24 100 0.992 (0.940–1.000)
AUROC area under the receiver operating characteristic curve, PWI perfusion-weighted imaging, DWI
diffusion-weighted imaging, DTI diffusion tensor imaging
Fig. 2 Receiver operating
characteristic (ROC) curve
comparison for all image sets (a)
and for apparent diffusion
coefficient (ADC) and fractional
anisotropy (FA) (b) to determine
detrusor muscle invasion in
patients with bladder cancer
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(P < 0.001) for pT2 tumours. Post-hoc corrected testing
showed no statistically significant differences across ROIs
placed in detrusor muscle for pTa-1 tumours. FA values
across three different ROIs in two groups of lesions are
shown in Fig. 5. Similar to ADC results, the overall tests
indicated that the distributions of FA differed among the
three ROIs in the two groups. The post-hoc analysis
showed that FA was significantly higher at the interface
between bladder mucosa and detrusor muscle than in nor-
mal muscle in T2 lesions (median ROI 2 = 0.36; IQR [0.30-
0.41] vs. median ROI 3 = 0.13; IQR [0.11-0.16]), while in
T1 tumours there was no such difference.
Both ADC and FA values were significantly different in
NMI and MIBC for ROI 2 (tumour/detrusor interface). ROC
analysis suggested (Fig. 2b) FA was significantly superior to
ADC (AUC for FA = 0.985 [95% CI 0.914–1.000] vs.
ADC = 0.889 [95% CI 0.782–0.955]).
Discussion
BCa diagnosis and staging currently relies on a combination
of non-invasive and invasive procedures. Whilst for many
patients this approach works well, others are left with undue
delays in obtaining TUR samples [16, 17], risk for dissemina-
tion of tumour cells at the time of TUR [18] and there can be
confusion about the need for radical treatment due to conflicts
between staging tools. To improve patient care, we evaluated
contemporary functional and anatomical mpMRI sequences.
Even though there is no accepted algorithm for radiological
imaging of bladder tumour, in recent years it has become
evident that MRI can match or be better than MDCT in diag-
nosing and staging bladder tumours by using standard MRI
protocols that rely on single sequences [10, 19]. Further stud-
ies have shown that DWI is a reliable technique in bladder
imaging [20, 21] and several authors demonstrated that adding
functional sequences to traditional protocols improves MRI
performance, reaching an accuracy of 92% [13] to 94% [22]
for protocols that included T2W, PWI and DWI. Overall, we
found that combined protocols offered greatest accuracy and
that these outperformed T2W plus PWI sequences. Our results
are equal to those in previous reports as far as T2W, DWI and
PWI are concerned [23], since the best accuracy is obtained by
interpreting the three sequences together.
We found only five cases that were misclassified by the
MRI examination. Of these, two T2 lesions had early micro-
scopic invasion at histopathology (T2a) and were classified as
NMIBC, whilst three pT1 lesions showing a very similar
Fig. 4 Apparent diffusion
coefficient (ADC) values
determined by diffusion-weighted
imaging (DWI) across three
different regions of interest
(ROIs) within the bladder tumour
and detrusor muscle
Fig. 3 K-trans values determined
by perfusion-weighted imaging
(PWI) across three different
regions of interest (ROIs) within
the bladder tumour and detrusor
muscle
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signal intensity of tumour and sub-mucosa at PWI were la-
belled as MIBC.
The innovation of the multiparametric evaluation in this
study is the introduction of the DTI imaging. In cases
where DWI and ADC sequences were inconclusive and
an interpretative doubt about bladder invasion existed, we
resorted to DTI as decisive tool, because it is also a water
diffusion elaboration. This study demonstrates the need to
integrate all the sequences information for an optimal blad-
der evaluation. The inclusion of DTI into an mp-MRI pro-
tocol allowed us to reach a diagnostic accuracy of 94% in
differentiating MIBC from NMIBC. In this study we also
demonstrate that the diffusion tensor parameters of inva-
sive and non-invasive bladder cancer differ significantly.
The FA values were not significantly different in normal
muscle tissue and interface between tumour and bladder
wall in NMIBC. The FA value was significantly higher at
the interface between tumour and bladder wall in MIBC. A
higher FA value is probably due to disruption of muscle
fibres organization where they are intersected by neoplastic
tissue; therefore it appears to be indicative of muscular
invasion. If these assumptions are confirmed, the calcula-
tion of anisotropy would become another non-invasive in-
strument for discriminating between invasive and non-
invasive bladder cancer forms, making it possible to plan
the most suitable therapeutic option.
As suggested by EAU guidelines on bladder cancer, if a
suspicious lesion is identified at imaging or endoscopy, it
should be followed by cystoscopy and/or resection.
According to the same guidelines, selected patients with
MIBC can be considered for multimodality bladder sparing
therapy andMRI can be used for local staging. Since mpMRI,
including DTI, has high accuracy in determining detrusor
muscle invasion, we suggest it could be included in the diag-
nostic evaluation of patients suspected of having BCa. If
mpMRI findings suggest muscle invasion, one wonders
whether in the future TURB could be excluded, as is being
tested by a new trial in the UK (HTA – 14/08/60). This could
theoretically expedite radical treatment and allow the urologist
to avoid unnecessary invasive procedures.
Our study had several limitations. The sample popula-
tion was relatively small and the distribution of T stages
was uneven, with a higher number of Ta-1 lesions com-
pared to T2. This reflects the BCa disease spectrum, but
limits the power in our report. DTI has some inherent lim-
itations, such as the difficulty in acquiring images with high
spatial resolution. This leads to possible partial volume ef-
fects so that ‘fibres’ with a different spatial orientation can
be found inside a single voxel, reducing the information
that tractographic processing is able to provide on finer
structural correlations. This may affect the ability to exam-
ine fine structures, such as the detrusor/mucosa interface.
Studies investigating normal bladder architecture in vivo
using DTI are lacking; nevertheless promising results have
been obtained in other body areas [24, 25].
In conclusion our approach suggests promising results for
the local staging of BCa using mpMRI. If our findings are
confirmed by others, we propose that mpMRI could become
the key diagnostic and staging tool of choice for BCa and
could allow urologist to alternate treatment pathways for pa-
tients with the highest need.
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